Cosmo N.V.

Status: Publicly traded

Direct answer

Cosmo N.V. is publicly traded on LSE under the ticker 0RGI.L.

Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a...

Can you invest in Cosmo N.V.?

Yes. Cosmo N.V. trades publicly on LSE as 0RGI.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cosmo N.V.

Detailed equity research is provided by MarketSnap.